On Monday, Salesforce, Inc (NYSE: CRM) issued a joint statement regarding its 2023 annual meeting and related director elections. Activist investor Elliott Investment Management decided not to proceed with director nominations, and Salesforce and Elliott will continue the productive working relationship. Salesforce's upcoming annual meeting will proceed in the ordinary course. As of January, Activist investor Elliott looked to nominate a slate of directors at Salesforce, signaling a fight for bo Read More...
Reuters
Pakistan defers decision on drug price rise as pharma firms struggle
KARACHI, Pakistan (Reuters) -Pakistan on Monday deferred a decision on a request by pharmaceutical firms to raise the prices of more than 100 medicines, prolonging a stand-off with an industry struggling to stem losses from soaring inflation and a weakened currency. The request was discussed during a meeting of the finance ministry’s Economic Coordination Committee, but no decision was taken, a ministry statement said. Since June, local and multinational companies, including Sanofi SA, have been lobbying the government to raise prices through industry lobby groups the Pharma Bureau and the Pakistan Pharmaceutical Manufacturer’s Association (PPMA).
Add Comment